Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Free Report) shares passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.28 and traded as low as $0.21. Northwest Biotherapeutics shares last traded at $0.23, with a volume of 3,564,085 shares trading hands.
Northwest Biotherapeutics Stock Performance
The stock has a fifty day simple moving average of $0.26 and a 200 day simple moving average of $0.28. The firm has a market cap of $296.24 million, a P/E ratio of -2.68 and a beta of -0.52.
Northwest Biotherapeutics (OTCMKTS:NWBO – Get Free Report) last announced its earnings results on Monday, March 31st. The biotechnology company reported ($0.02) earnings per share for the quarter. The business had revenue of $0.23 million for the quarter.
About Northwest Biotherapeutics
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer.
Featured Stories
- Five stocks we like better than Northwest Biotherapeutics
- Insider Trades May Not Tell You What You Think
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- What Are Growth Stocks and Investing in Them
- The 3 Most Talked About Investments on WallStreetBets Right Now
- What Investors Need to Know to Beat the Market
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
